Pluriomics Stem Cell technology

World Preclinical Congress 2017

Location: Boston, MA, USA
Date: June 12 – 16, 2017

Pluriomics will attend World Preclinical Congress 2017 in Boston, MA, USA

World Preclinical Congress (WPC) 2017 brings together chemists, biologists, pharmacologists, translational scientists and technology providers from academia and industry to discuss latest advances in preclinical drug discovery and development. As part of WPC 2017, the 10th annual conference on Predicting Drug Toxicity looks at the scientific and technological progress being made to better predict drug related toxicities at the early preclinical stages, and to better translate these findings to the clinic. 

Don’t miss the opportunity to meet Dr. Celine Hechard (VP Business Development & Marketing) at WPC2017 from June 13-16. She will be happy to tell you all about Pluriomics’ fully functional human iPSC-derived cardiomyocytes and the different assays that we develop in house for the prediction of cardiotoxicity. Don’t hesitate to contact her directly if you want to meet her: celine.hechard(at)pluriomics.com.

For more information on the event, please click here.